Related Experiment Videos
Solid-phase synthesis for the identification of high-affinity bivalent lectin ligands.
Sheryl D Debenham1, Phillip W Snyder, Eric J Toone
1Department of Chemistry, Duke University, Durham, North Carolina 27708-0346, USA.
The Journal of Organic Chemistry
|July 19, 2003
Summary
Developing effective carbohydrate therapeutics requires overcoming low binding affinities. Multivalency strategies, using peptide-linked ligands, enhance binding to lectins like concanavalin A, but require significant surface blocking to prevent unwanted interactions.
Area of Science:
- Biochemistry
- Carbohydrate Chemistry
- Drug Development
Background:
- Protein-carbohydrate interactions often exhibit low affinities, limiting therapeutic development.
- Multivalency, leveraging the oligomeric nature of lectins, offers a strategy to create high-affinity ligands.
- Solid-phase synthesis and evaluation of multivalent ligands enable rapid screening of linker structures.
Purpose of the Study:
- To synthesize and analyze peptide-linked, spatially segregated mono- and bivalent ligands for concanavalin A.
- To investigate the impact of ligand presentation on solid-phase binding using different resins (Tentagel and PEGA).
- To determine the surface blocking required to prevent intermolecular bivalent binding in solid-phase assays.
Main Methods:
- Solid-phase synthesis of peptide-linked mono- and bivalent ligands.
- Bead shaving protocols for creating spatially segregated binding sequences on Tentagel resins.
- Synthesis of ligands on PEGA resin to assess resin effects.
- Agglutination and calorimetric solution-phase binding studies.
Main Results:
- Intermolecular bivalent ligand binding was enhanced for bivalent ligands compared to monovalent ligands.
- Extensive surface blocking (99.9% on Tentagel, 99.99% on PEGA) is necessary to prevent intermolecular bivalent binding for concanavalin A.
- Solution-phase binding studies confirmed findings from solid-phase assays.
Conclusions:
- Multivalency can enhance ligand affinity for lectins, but careful control of solid-phase assay conditions is crucial.
- High levels of surface blocking are essential to ensure accurate solid-phase binding data, especially for multivalent ligands.
- The study provides critical insights into optimizing solid-phase assays for carbohydrate-based therapeutic development.